BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 24665980)

  • 1. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM; Marín JJ; Brites D
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T; Timonen S; Linden M; Suvitie P; Ekblad U
    BMC Gastroenterol; 2015 Jul; 15():92. PubMed ID: 26215400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.
    Joutsiniemi T; Timonen S; Leino R; Palo P; Ekblad U
    Arch Gynecol Obstet; 2014 Mar; 289(3):541-7. PubMed ID: 23978872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of corticotrophin-releasing hormone and its receptor in patients with intrahepatic cholestasis of pregnancy.
    Zhou F; He MM; Liu ZF; Zhang L; Gao BX; Wang XD
    Placenta; 2013 May; 34(5):401-6. PubMed ID: 23478074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial.
    Zhang L; Liu XH; Qi HB; Li Z; Fu XD; Chen L; Shao Y
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3770-6. PubMed ID: 26502869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted compensatory response mediated by Wolfram syndrome 1 protein and corticotrophin-releasing hormone family peptides in early-onset intrahepatic cholestasis pregnancy.
    Xu T; Zhou Z; Liu N; Deng C; Huang G; Zhou F; Liu X; Wang X
    Placenta; 2019 Aug; 83():63-71. PubMed ID: 31477210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
    Zapata R; Sandoval L; Palma J; Hernández I; Ribalta J; Reyes H; Sedano M; Tohá D; Silva JJ
    Liver Int; 2005 Jun; 25(3):548-54. PubMed ID: 15910492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
    Bacq Y; le Besco M; Lecuyer AI; Gendrot C; Potin J; Andres CR; Aubourg A
    Dig Liver Dis; 2017 Jan; 49(1):63-69. PubMed ID: 27825922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B; Özler S
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
    Bacq Y; Sentilhes L; Reyes HB; Glantz A; Kondrackiene J; Binder T; Nicastri PL; Locatelli A; Floreani A; Hernandez I; Di Martino V
    Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy.
    Liu Y; Qiao F; Liu H; Liu D
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):350-2. PubMed ID: 16961291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic expression of corticotropin-releasing hormone and urocortin in estrogen induced-cholestasis pregnant rat.
    Zhou F; Gao B; Deng C; Huang G; Xu T; Wang X
    Reprod Toxicol; 2016 Oct; 65():179-186. PubMed ID: 27492720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.